Research On The Connotation And Boundary Of Management Accounting In The Pharmaceutical Industry

At present,China is experiencing a critical period of industrial upgrading and enterprise transformation.Therefore,it is very necessary for the development of Chinese enterprises to integrate the management accounting ideas into the corporate management and to exert their value-raising functions.But how to implement it depends on the study of management accounting boundaries.This paper extends the boundary of management accounting into the daily financial analysis,business decision-making,cost control,comprehensive budget management,and strategic management of the enterprise,and effectively solves the problems that enterprises may face in daily production and operation.This article selects the pharmaceutical industry with a relatively high degree of concern.Through its industry R&D expenditures and the high risk of R&D process,it is determined that the management accounting ideology will focus on the boundary research issues in its R&D.The case of Hengrui Pharmaceutical,a leading company in the pharmaceutical and pharmaceutical industry,was selected as the case.Through its financial data and related business information,it conducted research on its R&D expenditures from various perspectives such as strategy formulation,risk management and control,and cost control,and finally made rational proposals for it.